The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I’m baffled how we are still debating this , as it’s clearly obvious ML & Co have found a solution to KILLING Covid 19 in everything you can “SEE” , additionally and massive is it can be added to existing things like your PC or phone for example , painted on all pipes , the list is endless. It’s obviously huge , not to mention solving the plastic issue being able to make it biodegradable . Listen and listen again to ML last interview posted earlier.
Your on the money their GingetheWinge, I don’t think peeps realise the next RNSs inc deals RNSs will propel this low cap with few shares .
Listen carefully
https://www.proactiveinvestors.co.uk/companies/news/924937/symphony-environmental-ceo-talks-coronavirus-breakthrough-for-its-antimicrobial-technology-924937.html
I remember noticing this to and thought that was very positive , I’m ready for some tasty news here as it’s been going a long time and any company that’s got a solution to the corona virus and biodegradable plastic solution should have a way higher MC, very much under the radar but not for long , a wee gem.
News very soon as no time for delay with Covid
This economic argument of d2w's relatively low cost (particularly when compared with other products and technologies, and their respective infrastructure requirements) is increasingly relevant in a number of Symphony's markets where, so much financial resource has and is being deployed by governments to support their economies during COVID-19 lockdowns and beyond.
Symphony has and is campaigning in a number of countries at what the Board perceive to be a key juncture in the history of environmental policy making. COVID-19 has reinforced the view that simply banning certain plastics, particularly single-use plastics is inconsistent with societal and economic needs. Symphony's campaigns have invariably focused on the markets where the Group is most active, and the Board is cautiously optimistic that legislators and opinion-formers in those jurisdictions will take meaningful steps towards further encouraging the use of Symphony's type of biodegradable technology over the next 12 months.
Such dialogue however is not restricted to Symphony's overseas markets and we continue our engagement with the UK government.
I am a long term investor who committed a substantial investment here last week . I’m not interested in worrying about competitors as SYM will only benefit from competition , I’m looking for 90p for a review on this investment , until then I look forward to the deals RNS coming in . I expect this to move up well next week ,
This is dirt cheap and going to rocket , I’m in around 35 and reckon it’s cheap as chips , the next RNS will see a re rate on the first big order then the next and so on , the MC is a steal for a takeover to . I’m in no doubt here.
It doesn’t matter if others are doing anything remotely like us as like a vaccine their is room for all to do well here , we have cracked this and I expect on the first big order this will multi bag , 57m MC is nothing .